Oncolytic viruses are viruses that preferentially infect and kill cancer cells. These viruses have the potential to be used as a cancer therapy, either alone or in combination with other treatments. There is a growing body of evidence to support the use of oncolytic viruses in the clinic, and several clinical trials are currently underway.
Some of the emerging trends in Oncolytic Virus therapy include the use of genetically modified viruses to target specific cancer cells, the use of oncolytic viruses in combination with other cancer therapies, and the use of oncolytic viruses to deliver cancer-fighting genes to tumor cells.